 ENGLEWOOD, Colo., July 13, 2021 PRNewswire -- Zynex, Inc. NASDAQ: ZYXI, an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that effective as of market open on July 14, 2021, its common stock has been approved for uplisting to the Nasdaq Global Select Market and will continue trading under its current ticker symbol ZYXI. 